Tiotropium
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2070 publications
The protective effects of BushenYiqi Decoction combined with tiotropium bromide on pathological changes in chronic obstructive pulmonary disease and regulation of the PI3K/AKT pathway.
Journal: Journal of Asian natural products research
Published: May 21, 2026
Inhaled Corticosteroids Plus Tiotropium Compared to Inhaled Corticosteroids Plus Montelukast in Children with Partly Controlled/Uncontrolled Asthma: A Non-Inferiority Trial - Authors' Reply-2.
Journal: Indian journal of pediatrics
Published: May 18, 2026
Inhaled Corticosteroids Plus Tiotropium Compared to Inhaled Corticosteroids Plus Montelukast in Children with Partly Controlled/Uncontrolled Asthma: A Non-Inferiority Trial - Correspondence-2.
Journal: Indian journal of pediatrics
Published: May 09, 2026
Can tiotropium add-on inhalation revolutionize therapy in elderly asthmatic patients? A treatable traits approach towards successful aging.
Journal: International journal of clinical pharmacology and therapeutics
Published: March 17, 2026
Inhaled Corticosteroids Plus Tiotropium Compared to Inhaled Corticosteroids Plus Montelukast in Children with Partly Controlled/Uncontrolled Asthma: A Non-Inferiority Trial - Authors' Reply.
Journal: Indian journal of pediatrics
Published: March 13, 2026
Inhaled Corticosteroids Plus Tiotropium Compared to Inhaled Corticosteroids Plus Montelukast in Children with Partly Controlled/Uncontrolled Asthma: A Non-Inferiority Trial - Correspondence.
Journal: Indian journal of pediatrics
Published: March 06, 2026
Add-on Choices Beyond Inhaled Corticosteroids in Pediatric Asthma: Where Do Tiotropium and Montelukast Fit?
Journal: Indian journal of pediatrics
Published: March 02, 2026
Comparative Effectiveness and Safety of LAMA-LABA Inhalers in Chronic Obstructive Pulmonary Disease.
Comparative Effectiveness and Safety of LAMA-LABA Inhalers in Chronic Obstructive Pulmonary Disease.
Journal: JAMA internal medicine
Published: February 23, 2026
Real-World Impact of Initial Dual Bronchodilation on Exercise Physiological Response and Health-Related Quality of Life in Newly Diagnosed, Treatment-Naïve Chronic Obstructive Pulmonary Disease.
Journal: Medicina (Kaunas, Lithuania)
Published: February 09, 2026
Real world pharmacovigilance study of FDA adverse event reporting system events for Spiriva Respimat.
Journal: Frontiers in medicine
Published: February 02, 2026
Effect of inhaled anticholinergics on bronchial secretions: a systematic review.
Journal: Frontiers in physiology
Published: January 27, 2026
Determination of Particle Size of Active Pharmaceutical Ingredients in Dry Powder Inhaler Formulations.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 14, 2026
Last Updated: 06/30/2026